A man with an enlarged prostate who consults three specialists can receive three different recommendations, each delivered with conviction. This is not usually dishonesty. It is that surgeons think in terms of removing the obstruction, interventional radiologists think in terms of reducing the blood supply, and everyone is most confident about the thing they do most often and do well.
Which means the burden falls on the patient to ask the right questions. This guide is the set of questions.
First: is the prostate even the problem?
Before comparing treatments, establish that a treatment is warranted and that it addresses your symptoms. Symptoms split into voiding complaints — weak stream, hesitancy, straining, dribbling, incomplete emptying — which point at obstruction, and storage complaints — urgency, frequency, waking at night — which point at the bladder and may or may not be caused by the obstruction.
This distinction decides how satisfied you will be afterwards. Relieving obstruction reliably improves voiding symptoms. It improves storage symptoms less reliably, because a bladder that has been remodelling for fifteen years does not always settle when the resistance is removed, and because waking at night frequently has nothing to do with the prostate at all. If your main complaint is getting up twice a night, read why you are awake at three before choosing anything.
Three numbers to know before deciding
Your symptom score, so improvement can be measured rather than remembered. Your post-void residual, which says whether the bladder is emptying. Your prostate volume, which determines which options are technically suitable and puts your PSA in context. A recommendation made without these is a recommendation made without the relevant facts.
The actual trade-offs
Watchful waiting is a legitimate choice for mild symptoms and an empty bladder, and it is not a euphemism for neglect — it means a scheduled review with the symptom score repeated. Medication works quickly, requires taking something daily, and has costs: alpha blockers commonly cause retrograde ejaculation and dizziness on standing, and 5-alpha reductase inhibitors shrink the gland over months while lowering libido in a minority and halving your PSA.
Among procedures, the honest comparison runs like this. The ejaculation-sparing options — UroLift, Rezum, and prostate artery embolization — preserve antegrade ejaculation in the large majority of men, and each gives a smaller or slower improvement in flow than resection does. UroLift works immediately and is the least durable. Rezum takes weeks to work as the treated tissue resorbs and needs a catheter in the interim. Embolization is performed through a pinhole in the wrist or groin, requires no anesthetic and no instrument passed through the penis, works for glands too large for most alternatives, and improves symptoms gradually over weeks to months rather than at once.
TURP and laser enucleation remove the obstructing tissue and give the largest, most durable improvement in flow that is available. They also require anesthesia and a catheter, and retrograde ejaculation is the usual outcome rather than a risk. For a man whose flow is his priority and whose ejaculation is not, that is a straightforward trade. For a man for whom the reverse is true, it is not.
What makes an option unsuitable
Gland anatomy matters. A large median lobe protruding into the bladder rules out some approaches. Very large glands narrow the field considerably and are where embolization and enucleation have the advantage. A bladder that has already failed — one that does not contract effectively — will not be rescued by relieving the obstruction, which is why urodynamics is worth doing before a procedure when the picture is ambiguous. Being on anticoagulation favours approaches that do not involve cutting.
The questions to ask
What proportion of my symptoms do you expect this to fix, and which ones will it not touch? What happens to my ejaculation, specifically, and what is the chance? How long until I feel the benefit, and what is the recovery? What is the chance I need a second procedure within five years? What anesthetic is involved, and where is it performed? And — the question that reveals the most — which of the other options did you consider, and why is this one better for me in particular?
A physician who answers all six without defensiveness is giving you advice. One who answers only the success rate is giving you a recommendation you cannot evaluate.
A note on where sedation happens
If a procedure is offered under sedation, it should be performed in a properly equipped and accredited surgical setting with a separate anesthesiologist present whose only job is watching you breathe. The anesthetic determines the requirement, not the size of the operation — a small procedure under deep sedation carries the airway risk of the sedation, not the risk of the incision. This is a standard we hold to, and it is worth asking about wherever you are treated.
The full argument is in Prostate Unlocked, and the practice's general rule — least invasive first, with costs stated before success rates — is set out in how we choose treatments.
Questions patients ask
Which treatment is best?
There is no single best, and anyone who says otherwise is describing what they do rather than what you need. The right choice depends on your gland size and shape, whether your bladder still empties, whether your symptoms are voiding or storage, what your anticoagulation situation is, and how much you value preserving ejaculation.
I want to keep normal ejaculation. What are my options?
UroLift, Rezum and prostate artery embolization all preserve it in the great majority of men. Say this at the beginning of the consultation rather than at the end — it genuinely narrows the field, and it is the single preference that most changes the recommendation.
How long does each one last?
Resection and enucleation are the most durable. Rezum and embolization sit in the middle with good medium-term durability. UroLift has the highest rate of needing something further. Retreatment is not a disaster; it is a cost to be weighed alongside the others.
Is embolization experimental?
No. It is an established procedure supported by randomised comparisons and guideline recognition, performed by interventional radiologists, and covered by most major insurers for appropriate indications. It is newer than resection and less widely available, which is not the same as experimental.
My prostate is very large. Does that limit me?
It rules out some options and favours others — embolization and enucleation both handle large glands well, whereas several of the office-based approaches have size limits. Very large glands are one of the clearest situations where the choice narrows on technical grounds rather than preference.
Make an appointment
Manhattan (212) 991-9991 · Forest Hills (718) 360-9550 · same-week visits and most major insurance accepted.